Statements of Operations-Additional Information (Tables)

9 Months Ended

Mar. 31, 2023

Statements of Operations-Additional Information

Schedule of revenues disaggregated by major product category and geographic region

Net Sales by Product Type

	Three Months				Nine Months
For the Periods Ended March 31	2023		2022		2023		2022
Animal Health
MFAs and other	$	93,217	$	84,330	$	283,186	$	259,812
Nutritional specialties		45,016		41,394		127,926		114,721
Vaccines		26,201		22,865		71,984		65,987
Total Animal Health	$	164,434	$	148,589	$	483,096	$	440,520
Mineral Nutrition		62,922		69,033		184,212		190,120
Performance Products		18,317		21,997		55,532		56,356
Total	$	245,673	$	239,619	$	722,840	$	686,996

Net Sales by Region

	Three Months				Nine Months
For the Periods Ended March 31	2023		2022		2023		2022
United States	$	148,529	$	146,820	$	433,716	$	412,284
Latin America and Canada		53,881		45,048		159,946		135,722
Europe, Middle East and Africa		28,174		29,931		85,518		90,889
Asia Pacific		15,089		17,820		43,660		48,101
Total	$	245,673	$	239,619	$	722,840	$	686,996

Schedule of interest expense, net

	Three Months				Nine Months
For the Periods Ended March 31	2023		2022		2023		2022
Interest expense, net
2021 Term A loan	$	1,450	$	2,208	$	4,836	$	6,745
Revolving credit facility		3,067		690		7,480		1,936
2022 Term loan		191		—		379		—
Amortization of debt issuance costs		188		147		514		442
Other		10		67		20		156
Interest expense		4,906		3,112		13,229		9,279
Interest income		(1,035)		(187)		(2,407)		(512)
	$	3,871	$	2,925	$	10,822	$	8,767

Schedule of depreciation and amortization

	Three Months				Nine Months
For the Periods Ended March 31	2023		2022		2023		2022
Depreciation and amortization
Depreciation of property, plant and equipment	$	6,067	$	6,214	$	18,177	$	17,792
Amortization of intangible assets		2,422		2,231		7,261		6,508
	$	8,489	$	8,445	$	25,438	$	24,300